This article has Open Peer Review reports available.
Efficacy of trypan blue in posterior capsulorhexis with optic capture in pediatric cataracts [ISRCTN48221688]
© Sharma et al; licensee BioMed Central Ltd. 2006
Received: 25 December 2004
Accepted: 16 March 2006
Published: 16 March 2006
To evaluate the efficacy of trypan blue (0.06%) in posterior capsulorhexis with optic capture in pediatric cataracts.
In this prospective randomized controlled study, trypan blue dye assisted posterior capsulorhexis with optic capture was performed in 18 eyes (group 1) and no dye was used for posterior capsulorhexis (group 2) in 17 eyes.
The mean size of the posterior capsulorhexis was 4.6 +/-1.77 mm and 4.0 +/- 0.93 mm in the group 1 and 2 respectively. Optic capture was possible in 17 eyes in the group 1 and 11 eyes in the group 2.
Trypan blue facilitates posterior capsulorhexis with optic capture of AcrySof IOL in cases of pediatric cataracts.
Maintenance of a clear visual axis after congenital cataract surgery is mandatory in order to obtain an optimal visual outcome. Proper management of the posterior capsule and early rehabilitation with amblyopia therapy are major factors, which decide the visual outcome of pediatric cataract surgery. The risk of posterior capsule opacification in children is almost 100% and prevents visual rehabilitation. Although Nd:YAG capsulotomy is a relatively safe procedure, its use is limited to older cooperative children. There is an increasing tendency towards intraocular lens (IOL) implantation in children, which requires at least a part of posterior capsule to be preserved. An anterior vitrectomy may be necessary to maintain clear visual axis even after performing primary posterior curvilinear capsulorhexis (PCCC)  as the anterior hyaloid acts as scaffold for lens epithelial migration and regenration.
Various therapeutic options which have been attempted to maintain a clear visual axis include lensectomy with anterior vitrectomy and primary posterior capsulorhexis with optic capture of the IOL with or without anterior vitrectomy[5, 6]. Gimbel and DeBroff proposed capturing a polymethylmethacrylate optic through primary posterior capsulorhexis to keep the visual axis clear. Hydrophobic acrylic intraocular lens (IOL) may be captured through a posterior capsulorhexis and combines the advantages of optic capture with a smaller incision with decreased inflammatory response. Performing posterior capsulorhexis with optic capture requires more surgical expertise because of thinner and more fragile posterior capsule, which makes it more difficult to visualize. Although, trypan blue has been successfully used for anterior capsule staining in white cataracts[10, 11], and in cataracts with corneal opacities. Its efficacy has also been reported in the staining of posterior plaque removal in pediatric cataracts but to the best of our knowledge there are very few reports[14, 15] of trypan blue dye assisted PCCC with optic capture in pediatric cataracts.
In this study, we evaluated the efficacy of trypan blue staining of the posterior capsule for the performance of PCCC with optic capture of hydrophobic acrylic IOL in pediatric cataracts.
This prospective randomized controlled study, thirty five eyes of 26 children, with age ranging from 5 years to 12 years with congenital or developmental cataract, who underwent lens aspiration with three piece AcrySof MA60BM (Alcon, Fort Worth, TX) (hydrophobic acrylic IOL) IOL implantation and optic capture from January 2002 to December 2002 were analyzed. In-group 1 (18 eyes); trypan blue dye assisted PCCC was done and in-group 2 (17 eyes); no dye was used. Informed consent was taken from the parents. Consecutive cases with visually significant lenticular opacity (3 mm or larger) were included. Eyes with traumatic cataract and associated ocular abnormalities were excluded.
The IOL power was prescribed as per the standard protocol followed in our centre. Emmetropic power was determined using the SRK II formula and the power of IOL to be inserted was calculated by under correcting by 10% in children between 2 and 8 years and emmetropic power in those above 8 years of age. In those cases, which had refractive errors and unilateral cataract, measurements in the fellow-eye were taken into consideration for determining IOL power. In very young and uncooperative children, axial length measurement and keratometry with the hand held automated keratometer was performed just prior to performing cataract surgery under general anesthesia.
The pupil was dilated with atropine 1% ointment instilled three times a day two days prior to the day before surgery. Homatropine eye drops 2 % were instilled four times, thirty minutes prior to surgery. All surgeries were performed under general anesthesia. A clear corneal incision 3.2 mm was made with the keratome at least 2.0 mm inside clear cornea. Sodium hyaluronate 1.4% (Healon GV, Advanced Medical Optics, Santa Ana, CA.) was injected and an anterior capsulorhexis was performed using a capsulorhexis forceps. After hydrodissection, the lens material was aspirated using an automated irrigation aspiration port or a bimanual irrigation/aspiration (I/A).
In order to stain the posterior capsule an air bubble was injected and trypan blue (Shah & Shah, Calcutta, India) 0.1 ml, 0.06 % was instilled under the air bubble. The dye was then washed with the balanced salt solution. Sodium hyaluronate 1.4% (Healon GV, Advanced Medical Optics, Santa Ana, CA.) was then instilled to inflate the capsular bag. A small nick was made on the posterior capsule and sodium hyaluronate 1.4% (Healon GV, Advanced Medical Optics, Santa Ana, CA.) was instilled below this nick to push the anterior vitreous face backwards. The stained edge of the capsule was then lifted and grasped with the capsulorhexis forceps and the posterior capsulorhexis was performed. Bimanual anterior vitrectomy was performed only in those cases in which vitreous prolapsed through the PCCC.
Postoperative topical treatment comprised of dexamethasone/neomycin eyedrops 6 times a day tapered over 2 weeks, diclofenac sodium eyedrops 3 times a day for 1 month, and tropicamide 1% eyedrops three times a day for 2 weeks. All patients were examined on the first postoperative day and then at regular intervals (i.e. 1 week, 2 weeks, 1 month and 3 months. At each visit, best corrected visual acuity, visual axis clarity and IOL related problems were noted.
Comparison of group 1 (trypan blue assisted PCCC) and group 2 (no dye was used).
No. of eyes
Age (mean ± SD)
Size of ACCC (mean ± SD)
Size of PCCC (mean ± SD)
optic capture of IOL in PCCC opening
8.3 ± 2.1 yrs
5.9 ± 1.74 mm
4.6 ± 1.77 mm
7.9 ± 2.4 yrs
5.8 ± 0.92 mm
4.0 ± 0.93 mm
PCCC is a posterior continuous curvilinear capsulotomy technique described by Gimbel. PCCC is also done for converting an irregular rupture of the posterior capsule into a circumscribed cut not extending to the equator[17, 18]. It can also be used for the removal of posterior capsular plaques in posterior subcapsular or polar cataracts.
Recently, the use of PCCC combined with optic capture of an IOL and/or anterior vitrectomy successfully evolved for delaying the development of posterior capsule opacification (PCO) or secondary membrane formation in pediatric cases. Primary posterior capsulotomy, in the form of PCCC, is especially important in younger children for maintaining a long-term clear visual axis in order to prevent the development of amblyopia.
Anterior capsule staining to facilitate anterior capsulorhexis is a well-established technique. Posterior capsulorhexis is technically more difficult to visualize, as it is thinner, more fragile and more elastic as compared to the anterior capsule. Frequent re-grasping and re-lifting of the capsular edge is required to facilitate the posterior capsulorhexis. Attempting PCCC in the presence of poor visibility associated with positive vitreous pressure is difficult and may cause an inadvertent radial tear extending toward the equator.
It is also more critical to achieve a posterior capsulorhexis especially in cases where optic capture is planned and a 'capturable posterior capsulorhexis' is mandatory. One of the most important factors for a "capturable" posterior capsulorhexis is the size of "IOL optic". While it is possible to capture the IOL with a optic diameter of 5.0 mm to 5.5 mm through a posterior capsulorhexis of approximately 3.75 mm to 4.0 mm. On the other hand, the IOL with 6 mm optic diameter may necessitate slightly larger (about 4.25 mm to 4.5 mm) posterior capsulorhexis for a successful IOL optic capture, without excessive ovalization of the posterior capsulorhexis opening. The staining of the posterior capsule with the trypan blue results in better visualization of the blue edge of the capsule beneath an underlying red reflex. The highlighted blue edge can then be easily re-grasped, re-lifted and re-oriented in a desired direction so as to achieve a circular and optimally sized posterior capsulorhexis.
In one case a posterior plaque was present and in another eye posterior capsular fibrosis was present which were delineated very well with the trypan blue dye. The morphology of the posterior capsule was discerned clearly so that a 'capturable' posterior capsulorhexis was facilitated.
Further, the spindle of the posterior capsule, which was the hallmark of achieving the capture of the posterior capsulorhexis, was better visualized. Thus the stained edge of the posterior capsulorhexis was manipulated more easily in the cases where trypan blue was used as compared to the cases in which no dye was used. The vitreous staining was not seen in any cases in the current series. However, possibility of inadvertent vitreous staining especially in a case of traumatic cataract with compromised zonular apparatus should be kept in mind.
The sizes of the anterior and the posterior capsulorhexis were comparable in the two groups. This may be attributed to the expertise and the surgical skills of the surgeons as experienced surgeons did the surgeries in both the groups. The difference in the two groups that is the stained and the non-stained group may become more significant if larger number of cases is taken. Further, trypan blue staining of the posterior capsule may be especially useful in congenital cataract surgeries, which are being undertaken by the novice surgeons or the surgeons who are in their learning curve.
As trypan blue is a potentially carcinogenic vital dye and its possible long-term side effects are unknown, the lowest effective concentration should be used particularly in childern. A concentration lower than 0.1% was effective in staining the anterior capsule even under dispersive viscoelastic material . In our study none of our IOL were stained with trypan blue.
Trypan blue even in the lower concentration (0.06%) facilitates appropriate staining of the posterior capsule for performing PCCC in pediatric cataracts. When trypan blue was used PCCC was complete in 94.4% compared to 64.7% when it was not used. We recommend that studies should be undertaken in larger number of subjects and results of achieving a posterior capsulorhexis and optic capture may be compared with and without trypan blue staining especially in the hands of novice surgeons.
- Knight-Nanan D, O'Keefe M, Bowell R: Outcome and complications of intraocular lenses in children with cataract. J Cataract Refract Surg. 1996, 22: 730-36.View ArticlePubMedGoogle Scholar
- Maltzman BA, Captuo AR, Wagner RS, Celebre LJ: Neodymium:YAG laser capsulotomy of secondary membranes in the pediatric population. Am Intraocular Implant Soc J. 1985, 11: 572-73.View ArticleGoogle Scholar
- BenEzra D, Cohen E: Posterior capsulectomy in pediatric cataract surgery; the necessity of choice. Ophthalmology. 1997, 104: 2168-74.View ArticlePubMedGoogle Scholar
- Nishi O: Fibrinous membrane formation on the posterior chamber lens during the early postoperative period. J Cataract Refract Surg. 1988, 14: 73-77.View ArticlePubMedGoogle Scholar
- Ram J, Brar GS, Kaushik S, Gupta A, Gupta A: Role of posterior capsulotomy with anterior vitrectomy and intraocular lens design and materials in reducing posterior capsule opacification after pediatric cataract surgery. J Cataract Refract Surg. 2003, 29: 1579-84. 10.1016/S0886-3350(03)00231-1.View ArticlePubMedGoogle Scholar
- Basti S, Ravishankar U, Gupta S: Results of a prospective evaluation of three methods of management of pediatric cataracts. Ophthalmology. 1996, 103: 713-20.View ArticlePubMedGoogle Scholar
- Gimbel HV, DeBroff BM: Posterior capsulorhexis with optic capture: maintaining a clear visual axis after pediatric cataract surgery. J Cataract Refract Surg. 1994, 20: 658-64.View ArticlePubMedGoogle Scholar
- Argento C, Badoza D, Ugrin C: Optic capture of the AcrySof intraocular lens in pediatric cataract surgery. J Cataract Refract Surg. 2001, 27: 1638-42. 10.1016/S0886-3350(00)00786-0.View ArticlePubMedGoogle Scholar
- Vasavada A, Desai J: Primary posterior capsulorhexis with or without anterior vitrectomy in congenital cataracts. J Cataract Refract Surg. 1997, 23: 645-51.View ArticlePubMedGoogle Scholar
- Kothari K, Jain SS, Shah NJ: Anterior capsular staining with trypan blue for capsulorhexis in mature and hypermature cataracts; a preliminary study. Indian J Ophthalmol. 2001, 49: 177-80.PubMedGoogle Scholar
- Melles GR, de Waard PW, Pameyer JH, Houdijn Beekhuis W: Trypan blue capsule staining to visualize the capsulorhexis in cataract surgery. J Cataract Refract Surg. 1999, 25 (1): 7-9. 10.1016/S0886-3350(99)80004-2.View ArticlePubMedGoogle Scholar
- Bhartiya P, Sharma N, Ray M, Sinha R, Vajpayee RB: Trypan blue assisted phacoemulsification in corneal opacities. Br J Ophthalmol. 2002, 86: 857-59. 10.1136/bjo.86.8.857.View ArticlePubMedPubMed CentralGoogle Scholar
- Sharma N, Gupta V, Vajpayee RB: Trypan-blue assisted posterior capsule plaque removal [letter]. J Cataract Refract Surg. 2002, 28: 916-17. 10.1016/S0886-3350(02)01416-5.View ArticlePubMedGoogle Scholar
- Saini JS, Jain AK, Sukhija J, Gupta P, Saroha V: Anterior and posterior capsulorhexis in pediatric cataract surgery with or without trypan blue dye: randomized prospective clinical study. J Cataract Refract Surg. 2003, 29: 1733-37. 10.1016/S0886-3350(03)00229-3.View ArticlePubMedGoogle Scholar
- Pandey SK, Werner L, Escobar-Gomez M, Werner LP, Apple DJ: Dye-enhanced cataract surgery. Part 3: posterior capsule staining to learn posterior continuous curvilinear capsulorhexis. J Cataract Refract Surg. 2000, 26: 1066-71. 10.1016/S0886-3350(00)00297-2.View ArticlePubMedGoogle Scholar
- Dahan E, Drusedau MUH: Choice of lens and dioptric power in pediatric pseudophakia. J Cataract refract Surg. 1997, 23: 618-23.View ArticlePubMedGoogle Scholar
- Gimbel HV: Posterior capsule tears using phacoemulsification: causes, prevention and management. Eur J Implant Refract Surg. 1990, 2: 63-69.View ArticleGoogle Scholar
- Castaneda VE, Legler UF, Tsai JC, et al: Posterior continuous capsulorhexis. An experimental study with clinical applications. Ophthalmology. 1992, 2: 63-69.Google Scholar
- Vasavada A, Singh R: Phacoemulsification in eyes with posterior polar cataract. J Cataract Refract Surg. 1999, 25: 238-45. 10.1016/S0886-3350(99)80133-3.View ArticlePubMedGoogle Scholar
- Pandey SK, Wilson ME, Trivedi RH, et al: Pediatric cataract surgery and intraocular lens implantation: current techniques, complications and management. Int Ophthalmol Clin. 2001, 41: 175-96. 10.1097/00004397-200107000-00013.View ArticlePubMedGoogle Scholar
- Chowdhury PK, Raj SM, Vasavada AR: Inadvertent staining of the vitreous with trypan blue. J Cataract Refract Surg. 2004, 30: 274-76. 10.1016/j.jcrs.2003.12.002.View ArticlePubMedGoogle Scholar
- Yetik H, Devranoglu K, Ozkan S: Determining the lowest trypan blue concentration that satisfactorily stains the anterior capsule. J Cataract Refract Surg. 2002, 28: 988-91. 10.1016/S0886-3350(02)01217-8.View ArticlePubMedGoogle Scholar
- The pre-publication history for this paper can be accessed here:http://www.biomedcentral.com/1471-2415/6/12/prepub
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.